Dual-targeting drug for EBV-related cancers
A Hong Kong Baptist University-led (HKBU) research team has developed a novel drug which has…
Browsing: EBV
Research team develops novel antiviral targeted drug for nasopharyngeal cancer
A research team led by Hong Kong Baptist University (HKBU) has developed a novel anti-Epstein-Barr…
Vaccination against Epstein-Barr virus might reduce the risk of developing Hodgkin’s lymphoma, study suggests
Cells of certain blood cancers such as Hodgkin’s lymphoma carry the protein CD30 on their…